Report Detail
Global and United States Transdermal Skin Patch Market Insights, Forecast to 2026
- RnM4189478 |
- 04 September, 2020 |
- Global |
- 142 Pages |
- QYResearch |
- Pharma & Healthcare
Transdermal Skin Patch market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Transdermal Skin Patch market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Transdermal Skin Patch market is segmented into
Fentanyl Transdermal Skin Patch
Nicotine Transdermal Skin Patch
Clonidine Transdermal Skin Patch
Buprenorphine Transdermal Skin Patch
Segment by Application, the Transdermal Skin Patch market is segmented into
Relieve Severe Pain
Stop Smoking Cigarettes
Treat An Overactive Bladder
Others
Regional and Country-level Analysis
The Transdermal Skin Patch market is analysed and market size information is provided by regions (countries).
The key regions covered in the Transdermal Skin Patch market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Transdermal Skin Patch Market Share Analysis
Transdermal Skin Patch market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Transdermal Skin Patch business, the date to enter into the Transdermal Skin Patch market, Transdermal Skin Patch product introduction, recent developments, etc.
The major vendors covered:
Hisamitsu Pharmaceutical
Novartis
Johnson & Johnson
Teikoku Pharma
Mylan
Actavis
Mundipharma
Henan Lingrui Pharmaceutical
Changzhou Siyao
Rfl Pharmaceutical
Luye Pharma Group Ltd.
Purdue Pharma L.P.
Teva Pharmaceutical Industries Ltd.
1 Study Coverage
- 1.1 Transdermal Skin Patch Product Introduction
- 1.2 Market Segments
- 1.3 Key Transdermal Skin Patch Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Transdermal Skin Patch Market Size Growth Rate by Type
- 1.4.2 Fentanyl Transdermal Skin Patch
- 1.4.3 Nicotine Transdermal Skin Patch
- 1.4.4 Clonidine Transdermal Skin Patch
- 1.4.5 Buprenorphine Transdermal Skin Patch
- 1.5 Market by Application
- 1.5.1 Global Transdermal Skin Patch Market Size Growth Rate by Application
- 1.5.2 Relieve Severe Pain
- 1.5.3 Stop Smoking Cigarettes
- 1.5.4 Treat An Overactive Bladder
- 1.5.5 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Transdermal Skin Patch Market Size, Estimates and Forecasts
- 2.1.1 Global Transdermal Skin Patch Revenue 2015-2026
- 2.1.2 Global Transdermal Skin Patch Sales 2015-2026
- 2.2 Global Transdermal Skin Patch, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Transdermal Skin Patch Historical Market Size by Region (2015-2020)
- 2.3.1 Global Transdermal Skin Patch Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.3.2 Global Transdermal Skin Patch Retrospective Market Scenario in Revenue by Region: 2015-2020
- 2.4 Transdermal Skin Patch Market Estimates and Projections by Region (2021-2026)
- 2.4.1 Global Transdermal Skin Patch Sales Forecast by Region (2021-2026)
- 2.4.2 Global Transdermal Skin Patch Revenue Forecast by Region (2021-2026)
3 Global Transdermal Skin Patch Competitor Landscape by Players
- 3.1 Global Top Transdermal Skin Patch Sales by Manufacturers
- 3.1.1 Global Transdermal Skin Patch Sales by Manufacturers (2015-2020)
- 3.1.2 Global Transdermal Skin Patch Sales Market Share by Manufacturers (2015-2020)
- 3.2 Global Transdermal Skin Patch Manufacturers by Revenue
- 3.2.1 Global Transdermal Skin Patch Revenue by Manufacturers (2015-2020)
- 3.2.2 Global Transdermal Skin Patch Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Transdermal Skin Patch Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Transdermal Skin Patch Revenue in 2019
- 3.2.5 Global Transdermal Skin Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Global Transdermal Skin Patch Price by Manufacturers
- 3.4 Global Transdermal Skin Patch Manufacturing Base Distribution, Product Types
- 3.4.1 Transdermal Skin Patch Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Transdermal Skin Patch Product Type
- 3.4.3 Date of International Manufacturers Enter into Transdermal Skin Patch Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Transdermal Skin Patch Market Size by Type (2015-2020)
- 4.1.1 Global Transdermal Skin Patch Sales by Type (2015-2020)
- 4.1.2 Global Transdermal Skin Patch Revenue by Type (2015-2020)
- 4.1.3 Transdermal Skin Patch Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Transdermal Skin Patch Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Transdermal Skin Patch Sales Forecast by Type (2021-2026)
- 4.2.2 Global Transdermal Skin Patch Revenue Forecast by Type (2021-2026)
- 4.2.3 Transdermal Skin Patch Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Transdermal Skin Patch Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Transdermal Skin Patch Market Size by Application (2015-2020)
- 5.1.1 Global Transdermal Skin Patch Sales by Application (2015-2020)
- 5.1.2 Global Transdermal Skin Patch Revenue by Application (2015-2020)
- 5.1.3 Transdermal Skin Patch Price by Application (2015-2020)
- 5.2 Transdermal Skin Patch Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Transdermal Skin Patch Sales Forecast by Application (2021-2026)
- 5.2.2 Global Transdermal Skin Patch Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Transdermal Skin Patch Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
- 6.1 United States Transdermal Skin Patch Market Size YoY Growth 2015-2026
- 6.1.1 United States Transdermal Skin Patch Sales YoY Growth 2015-2026
- 6.1.2 United States Transdermal Skin Patch Revenue YoY Growth 2015-2026
- 6.1.3 United States Transdermal Skin Patch Market Share in Global Market 2015-2026
- 6.2 United States Transdermal Skin Patch Market Size by Players (International and Local Players)
- 6.2.1 United States Top Transdermal Skin Patch Players by Sales (2015-2020)
- 6.2.2 United States Top Transdermal Skin Patch Players by Revenue (2015-2020)
- 6.3 United States Transdermal Skin Patch Historic Market Review by Type (2015-2020)
- 6.3.1 United States Transdermal Skin Patch Sales Market Share by Type (2015-2020)
- 6.3.2 United States Transdermal Skin Patch Revenue Market Share by Type (2015-2020)
- 6.3.3 United States Transdermal Skin Patch Price by Type (2015-2020)
- 6.4 United States Transdermal Skin Patch Market Estimates and Forecasts by Type (2021-2026)
- 6.4.1 United States Transdermal Skin Patch Sales Forecast by Type (2021-2026)
- 6.4.2 United States Transdermal Skin Patch Revenue Forecast by Type (2021-2026)
- 6.4.3 United States Transdermal Skin Patch Price Forecast by Type (2021-2026)
- 6.5 United States Transdermal Skin Patch Historic Market Review by Application (2015-2020)
- 6.5.1 United States Transdermal Skin Patch Sales Market Share by Application (2015-2020)
- 6.5.2 United States Transdermal Skin Patch Revenue Market Share by Application (2015-2020)
- 6.5.3 United States Transdermal Skin Patch Price by Application (2015-2020)
- 6.6 United States Transdermal Skin Patch Market Estimates and Forecasts by Application (2021-2026)
- 6.6.1 United States Transdermal Skin Patch Sales Forecast by Application (2021-2026)
- 6.6.2 United States Transdermal Skin Patch Revenue Forecast by Application (2021-2026)
- 6.6.3 United States Transdermal Skin Patch Price Forecast by Application (2021-2026)
7 North America
- 7.1 North America Transdermal Skin Patch Market Size YoY Growth 2015-2026
- 7.2 North America Transdermal Skin Patch Market Facts & Figures by Country
- 7.2.1 North America Transdermal Skin Patch Sales by Country (2015-2020)
- 7.2.2 North America Transdermal Skin Patch Revenue by Country (2015-2020)
- 7.2.3 U.S.
- 7.2.4 Canada
8 Europe
- 8.1 Europe Transdermal Skin Patch Market Size YoY Growth 2015-2026
- 8.2 Europe Transdermal Skin Patch Market Facts & Figures by Country
- 8.2.1 Europe Transdermal Skin Patch Sales by Country
- 8.2.2 Europe Transdermal Skin Patch Revenue by Country
- 8.2.3 Germany
- 8.2.4 France
- 8.2.5 U.K.
- 8.2.6 Italy
- 8.2.7 Russia
9 Asia Pacific
- 9.1 Asia Pacific Transdermal Skin Patch Market Size YoY Growth 2015-2026
- 9.2 Asia Pacific Transdermal Skin Patch Market Facts & Figures by Country
- 9.2.1 Asia Pacific Transdermal Skin Patch Sales by Region (2015-2020)
- 9.2.2 Asia Pacific Transdermal Skin Patch Revenue by Region
- 9.2.3 China
- 9.2.4 Japan
- 9.2.5 South Korea
- 9.2.6 India
- 9.2.7 Australia
- 9.2.8 Taiwan
- 9.2.9 Indonesia
- 9.2.10 Thailand
- 9.2.11 Malaysia
- 9.2.12 Philippines
- 9.2.13 Vietnam
10 Latin America
- 10.1 Latin America Transdermal Skin Patch Market Size YoY Growth 2015-2026
- 10.2 Latin America Transdermal Skin Patch Market Facts & Figures by Country
- 10.2.1 Latin America Transdermal Skin Patch Sales by Country
- 10.2.2 Latin America Transdermal Skin Patch Revenue by Country
- 10.2.3 Mexico
- 10.2.4 Brazil
- 10.2.5 Argentina
11 Middle East and Africa
- 11.1 Middle East and Africa Transdermal Skin Patch Market Size YoY Growth 2015-2026
- 11.2 Middle East and Africa Transdermal Skin Patch Market Facts & Figures by Country
- 11.2.1 Middle East and Africa Transdermal Skin Patch Sales by Country
- 11.2.2 Middle East and Africa Transdermal Skin Patch Revenue by Country
- 11.2.3 Turkey
- 11.2.4 Saudi Arabia
- 11.2.5 U.A.E
12 Company Profiles
- 12.1 Hisamitsu Pharmaceutical
- 12.1.1 Hisamitsu Pharmaceutical Corporation Information
- 12.1.2 Hisamitsu Pharmaceutical Description and Business Overview
- 12.1.3 Hisamitsu Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
- 12.1.4 Hisamitsu Pharmaceutical Transdermal Skin Patch Products Offered
- 12.1.5 Hisamitsu Pharmaceutical Recent Development
- 12.2 Novartis
- 12.2.1 Novartis Corporation Information
- 12.2.2 Novartis Description and Business Overview
- 12.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 12.2.4 Novartis Transdermal Skin Patch Products Offered
- 12.2.5 Novartis Recent Development
- 12.3 Johnson & Johnson
- 12.3.1 Johnson & Johnson Corporation Information
- 12.3.2 Johnson & Johnson Description and Business Overview
- 12.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
- 12.3.4 Johnson & Johnson Transdermal Skin Patch Products Offered
- 12.3.5 Johnson & Johnson Recent Development
- 12.4 Teikoku Pharma
- 12.4.1 Teikoku Pharma Corporation Information
- 12.4.2 Teikoku Pharma Description and Business Overview
- 12.4.3 Teikoku Pharma Sales, Revenue and Gross Margin (2015-2020)
- 12.4.4 Teikoku Pharma Transdermal Skin Patch Products Offered
- 12.4.5 Teikoku Pharma Recent Development
- 12.5 Mylan
- 12.5.1 Mylan Corporation Information
- 12.5.2 Mylan Description and Business Overview
- 12.5.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
- 12.5.4 Mylan Transdermal Skin Patch Products Offered
- 12.5.5 Mylan Recent Development
- 12.6 Actavis
- 12.6.1 Actavis Corporation Information
- 12.6.2 Actavis Description and Business Overview
- 12.6.3 Actavis Sales, Revenue and Gross Margin (2015-2020)
- 12.6.4 Actavis Transdermal Skin Patch Products Offered
- 12.6.5 Actavis Recent Development
- 12.7 Mundipharma
- 12.7.1 Mundipharma Corporation Information
- 12.7.2 Mundipharma Description and Business Overview
- 12.7.3 Mundipharma Sales, Revenue and Gross Margin (2015-2020)
- 12.7.4 Mundipharma Transdermal Skin Patch Products Offered
- 12.7.5 Mundipharma Recent Development
- 12.8 Henan Lingrui Pharmaceutical
- 12.8.1 Henan Lingrui Pharmaceutical Corporation Information
- 12.8.2 Henan Lingrui Pharmaceutical Description and Business Overview
- 12.8.3 Henan Lingrui Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
- 12.8.4 Henan Lingrui Pharmaceutical Transdermal Skin Patch Products Offered
- 12.8.5 Henan Lingrui Pharmaceutical Recent Development
- 12.9 Changzhou Siyao
- 12.9.1 Changzhou Siyao Corporation Information
- 12.9.2 Changzhou Siyao Description and Business Overview
- 12.9.3 Changzhou Siyao Sales, Revenue and Gross Margin (2015-2020)
- 12.9.4 Changzhou Siyao Transdermal Skin Patch Products Offered
- 12.9.5 Changzhou Siyao Recent Development
- 12.10 Rfl Pharmaceutical
- 12.10.1 Rfl Pharmaceutical Corporation Information
- 12.10.2 Rfl Pharmaceutical Description and Business Overview
- 12.10.3 Rfl Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
- 12.10.4 Rfl Pharmaceutical Transdermal Skin Patch Products Offered
- 12.10.5 Rfl Pharmaceutical Recent Development
- 12.11 Hisamitsu Pharmaceutical
- 12.11.1 Hisamitsu Pharmaceutical Corporation Information
- 12.11.2 Hisamitsu Pharmaceutical Description and Business Overview
- 12.11.3 Hisamitsu Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
- 12.11.4 Hisamitsu Pharmaceutical Transdermal Skin Patch Products Offered
- 12.11.5 Hisamitsu Pharmaceutical Recent Development
- 12.12 Purdue Pharma L.P.
- 12.12.1 Purdue Pharma L.P. Corporation Information
- 12.12.2 Purdue Pharma L.P. Description and Business Overview
- 12.12.3 Purdue Pharma L.P. Sales, Revenue and Gross Margin (2015-2020)
- 12.12.4 Purdue Pharma L.P. Products Offered
- 12.12.5 Purdue Pharma L.P. Recent Development
- 12.13 Teva Pharmaceutical Industries Ltd.
- 12.13.1 Teva Pharmaceutical Industries Ltd. Corporation Information
- 12.13.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
- 12.13.3 Teva Pharmaceutical Industries Ltd. Sales, Revenue and Gross Margin (2015-2020)
- 12.13.4 Teva Pharmaceutical Industries Ltd. Products Offered
- 12.13.5 Teva Pharmaceutical Industries Ltd. Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Transdermal Skin Patch Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Transdermal Skin Patch Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Transdermal Skin Patch. Industry analysis & Market Report on Transdermal Skin Patch is a syndicated market report, published as Global and United States Transdermal Skin Patch Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of Transdermal Skin Patch market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
